Nicholas Watson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nicholas Watson has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aidan Callinan
Department of Radiology Redcliffe Hospital Redcliffe Queensland Australia
1 shared publication - Brett Droder
Jamieson Trauma Institute Brisbane Queensland Australia
1 shared publication - Craig Hacking
Radiology Department Princess Alexandra Hospital Brisbane Queensland Australia
1 shared publication - Gary Mitchell
Royal Brisbane and Women’s Hospital Brisbane QLD
1 shared publication Jie Ding
Lime Radiology, Integral Diagnostics (IDX), Margate Margate Queensland Australia
1 shared publicationLi Wang
Department of Urology Redcliffe Hospital Redcliffe Queensland Australia
1 shared publication
Latest Publications
- Open Access
- 17 March 2025
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 69 (3) , 373-380
Adverse Reactions to Urinary Contrast: A Case Report and Systematic Review
Objective: Intra‐urinary iodinated contrast agents are commonly used in urological procedures, but research of allergic reactions is rare. This study presents a rare case of an intra‐urinary contrast reaction, followed by a comprehensive literature review of adverse reactions to intra‐urinary contrast.Methods: PubMed and Embase databases were searched using Medical Subject Headings terms related to urinary procedures and contrast reactions, with additional articles identified through reference reviews.Results: Adverse reactions to intra‐urinary contrast agents are rare, with most reactions being mild. Severe reactions were infrequent, and both patient‐related and contrast‐related factors were identified as influencing the likelihood of adverse events. However, the role of previous intravenous contrast reactions as a predisposing factor and the effectiveness of premedication in preventing these reactions remain uncertain. Furthermore, clinical guidelines for diagnosing and managing such reactions are lacking.Conclusion: Although urinary contrast reactions are uncommon, they can range from mild to severe, including anaphylaxis. Further research is needed to establish standardized premedication protocols and management strategies, and a better understanding of predisposing factors could enhance patient safety in urological procedures involving contrast agents.
- 17 March 2025
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 69 (3) , 373-380
Open AccessAdverse Reactions to Urinary Contrast: A Case Report and Systematic Review
Objective: Intra‐urinary iodinated contrast agents are commonly used in urological procedures, but research of allergic reactions is rare. This study presents a rare case of an intra‐urinary contrast reaction, followed by a comprehensive literature review of adverse reactions to intra‐urinary contrast.Methods: PubMed and Embase databases were searched using Medical Subject Headings terms related to urinary procedures and contrast reactions, with additional articles identified through reference reviews.Results: Adverse reactions to intra‐urinary contrast agents are rare, with most reactions being mild. Severe reactions were infrequent, and both patient‐related and contrast‐related factors were identified as influencing the likelihood of adverse events. However, the role of previous intravenous contrast reactions as a predisposing factor and the effectiveness of premedication in preventing these reactions remain uncertain. Furthermore, clinical guidelines for diagnosing and managing such reactions are lacking.Conclusion: Although urinary contrast reactions are uncommon, they can range from mild to severe, including anaphylaxis. Further research is needed to establish standardized premedication protocols and management strategies, and a better understanding of predisposing factors could enhance patient safety in urological procedures involving contrast agents.
- 7 October 2024
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 68 (7) , 796-804
Head, face and neck injury patterns for electric scooter accidents identified on computed tomography scanning: Does legislative change enforcing safer riding practices have an impact on morbidity for significant head, face and neck trauma?
Introduction: The purpose of this study is to review whether legislative change enforcing safer riding conditions for Electric Scooters (E‐Scooter), regardless of other factors, had an impact on reducing significant head, facial and neck trauma. Additionally, to identify the radiological injury patterns for head, face and neck injuries identified on CT imaging for a patient's initial presentation to the emergency department (ED) resulting from an E‐Scooter accident.Methods: A retrospective single‐centre observational study at a metropolitan tertiary ED of patients presenting after an E‐Scooter accident comparing 6 months before and after legislative change.Results: Four hundred and forty‐three patients presented following an E‐Scooter accident: 191 patients 6 months before and 252 patients 6 months after legislative change. One hundred and sixty‐two patients pre‐ and 217 patients post‐legislative change had negative CT studies. Twenty‐nine patients pre‐ and 35 patients post‐legislative change had CT studies demonstrating significant head, face or neck trauma. The most common type of intracranial bleeding was subarachnoid haemorrhage followed by subdural haemorrhage with a significant proportion (41%) presenting with multi‐factorial intracranial bleeding. There was no specific injury pattern involving the cranial vault or cervical spine. Of the patients presenting with a significant injury, facial bones were the most common injury site (84% (n = 54)). The most common site of facial fractures was the nasal bones followed by dental trauma and maxillary fractures.Conclusion: This single‐centre, retrospective observational study has shown no reduction in serious head, neck and facial injuries. Large‐scale, multicentre studies will need to be undertaken to understand the true impact of legislative change.
- 7 October 2024
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 68 (7) , 796-804
Head, face and neck injury patterns for electric scooter accidents identified on computed tomography scanning: Does legislative change enforcing safer riding practices have an impact on morbidity for significant head, face and neck trauma?
Introduction: The purpose of this study is to review whether legislative change enforcing safer riding conditions for Electric Scooters (E‐Scooter), regardless of other factors, had an impact on reducing significant head, facial and neck trauma. Additionally, to identify the radiological injury patterns for head, face and neck injuries identified on CT imaging for a patient's initial presentation to the emergency department (ED) resulting from an E‐Scooter accident.Methods: A retrospective single‐centre observational study at a metropolitan tertiary ED of patients presenting after an E‐Scooter accident comparing 6 months before and after legislative change.Results: Four hundred and forty‐three patients presented following an E‐Scooter accident: 191 patients 6 months before and 252 patients 6 months after legislative change. One hundred and sixty‐two patients pre‐ and 217 patients post‐legislative change had negative CT studies. Twenty‐nine patients pre‐ and 35 patients post‐legislative change had CT studies demonstrating significant head, face or neck trauma. The most common type of intracranial bleeding was subarachnoid haemorrhage followed by subdural haemorrhage with a significant proportion (41%) presenting with multi‐factorial intracranial bleeding. There was no specific injury pattern involving the cranial vault or cervical spine. Of the patients presenting with a significant injury, facial bones were the most common injury site (84% (n = 54)). The most common site of facial fractures was the nasal bones followed by dental trauma and maxillary fractures.Conclusion: This single‐centre, retrospective observational study has shown no reduction in serious head, neck and facial injuries. Large‐scale, multicentre studies will need to be undertaken to understand the true impact of legislative change.
- 1 January 1991
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 12 (6) , 374-378
Effects of captopril on glucose tolerance in elderly patients with congestive cardiac failure
A prospective study was carried out to investigate the effects of the ACE inhibitor captopril on glucose tolerance in 14 elderly patients, aged 76 to 89years, who had co-incident cardiac failure and stable Type II diabetes mellitus. Patients were maintained on their diet and diabetic therapy and were given 12.5 mg captopril twice daily. Clinical findings, including signs of cardiac failure, body weight and blood pressure, biochemical profile and chest X-ray appearance were documented at each visit. Blood glucose tolerance testing was carried out immediately before starting captopril and again 28 days later. A reduction in symptoms of heart failure occurred in all patients and 5 of them reduced their New York Heart Association grade of heart failure. Significant improvement in glucose tolerance occurred in all patients. Four were able to reduce hypoglycaemic therapy and 1 was able to stop his hypoglycaemic agents. This potentially valuable additional benefit of captopril in improving glucose tolerance has not yet been shown to occur with other A CE inhibitors.
- 1 January 1991
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 12 (6) , 374-378
Effects of captopril on glucose tolerance in elderly patients with congestive cardiac failure
A prospective study was carried out to investigate the effects of the ACE inhibitor captopril on glucose tolerance in 14 elderly patients, aged 76 to 89years, who had co-incident cardiac failure and stable Type II diabetes mellitus. Patients were maintained on their diet and diabetic therapy and were given 12.5 mg captopril twice daily. Clinical findings, including signs of cardiac failure, body weight and blood pressure, biochemical profile and chest X-ray appearance were documented at each visit. Blood glucose tolerance testing was carried out immediately before starting captopril and again 28 days later. A reduction in symptoms of heart failure occurred in all patients and 5 of them reduced their New York Heart Association grade of heart failure. Significant improvement in glucose tolerance occurred in all patients. Four were able to reduce hypoglycaemic therapy and 1 was able to stop his hypoglycaemic agents. This potentially valuable additional benefit of captopril in improving glucose tolerance has not yet been shown to occur with other A CE inhibitors.